Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: Possible role of oestradiol and natural killer cells

British Journal of Cancer

Volumn 74, Issue 12, 1996, Pages 1900-1907

  Ben Eliyahu, S ^a   Page, G G ^b   Shakhar, G ^a   Taylor, A N ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Immunity; MADB106; Menstrual cycle; Oestradiol; Oestrous cycle

Indexed keywords

ESTRADIOL; ESTRADIOL BENZOATE; ESTRADIOL RECEPTOR; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; HORMONAL CARCINOGENESIS; METASTASIS; NATURAL KILLER CELL; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT;

EID: 0030443835     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.651     Document Type: Article

References (60)

1. ADER R, FELTEN DL AND COHEN N. (1991). Psychoneuroimmunology. Academic Press: San Diego.
2. BADWE RA, GREGORY WM, CHAUDARY MA, RICHARDS MA, BENTLEY AE, RUBENS RD AND FENTIMAN IS. (1991). Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet, 337, 1261-1264.
3. BAKER DA, SALVATORE W AND MILCH PO. (1989). Effect of low-dose oral contraceptives on natural killer cell activity. Contraception, 39, 119-124.
4. BARAL E, KWOK S AND BERCZI I. (1991). The influence of estradiol and tamoxifen on the mixed lymphocyte reaction in rats. Immunopharmacology, 21, 191-198.
5. BARLOZZARI T, REYNODS CW AND HERBERMAN RB. (1983). In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats. J. Immunol., 131, 1024-1207.
6. BARLOZZARI T, LEONHARDT J, WILTROUT RH, HERBERMAN RB AND REYNOLDS CW. (1985). Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J. Immunol., 134, 2783-2789.
7. BEN-ELIYAHU S AND PAGE GG. (1992). In vivo assessment of natural killer cell activity in rats. Prog. Neuroendocrinimmunol., 5, 199-214.
8. BEN-ELIYAHU S, PAGE GG, YIRMIYA R, TAYLOR AN AND LIEBESKIND JC. (1993). Sympathetic modulation of natural killer cell activity and metastatic growth: a role for adrenal epinephrine. Paper presented at Research Perspectives in Psychoneuroimmunology IV, Boulder, Colorado, USA.
9. BEN-ELIYAHU S, YIRMIYA R, LIEBESKIND JC, TAYLOR AN AND GALE RP. (1991). Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by immune system. Brain Behav. Immunol., 5, 193-205.
10. BEN-ELIYAHU S, PAGE GG, YIRMIYA R AND TAYLOR AN. (1996). Acute alcohol intoxication suppresses natural killer cell activity in vivo and promotes tumor metastasis. Nature Med., 2, 457-460.
11. CALLEWAERT DM, MOUDGIL VK, RADCLIFF G AND WAITE R. (1991). Hormone specific regulation of natural killer cells by cortisol: direct inactivation of the cytotoxic function of cloned human NK cells without an effect on cellular proliferation. Fed. Eur. Biochem. Soc., 285, 108-110.
12. CHAMBERS WH, VUJANOVIC NL AND HISERODT JC. (1989). Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cell. J. Exp. Med., 169, 1373-1389.
13. dim subpopulations of rat natural killer cells. J. Immunol., 148, 3658-3665.
14. D'AMOUR FE AND BLOOD FR. (1954). Manual for Laboratory Work in Mammalian Physiology. Chicago Press: Chicago.
15. DAVIDSON NE AND ABELOFF MD. (1993). Menstrual effects on surgical treatment for breast cancer. Cancer Treatment Reviews, 19, 105-112.
16. EVERETT JW. (1989). Neurobiology of Reproduction in the Female Rat. Springer: Berlin.
17. GABRILOVAC J, ZADJELOVIC J, OSMAK M, SUCHANEK E, ZUPANOVIC Z AND BORANIC M. (1988). NK cell activity and estrogen hormones levels during normal human pregnancy. Gynecol. Obstet. Invest., 25, 165-172.
18. GEIER A, HAIMSOHN M AND LUNENFELD B. (1982). Evidence of the origin of the unoccupied oestrogen receptor in nuclei of a human breast-cancer cell line (MCH7). Biochem. J., 202, 687-691.
19. GORELIK E, WILTROUT RH, OKUMURA K, HABU S AND HERBERMAN RB. (1982). Role of NK cells in the control of metastatic spread and growth of minor cells in mice. Int. J. Cancer, 30, 107-112.
20. GRUBER SA, HOFFMAN RA, SOTHERN RB, LAKATUA D, CARLSON A, SIMMONS RL AND HRUSHESKY WJM. (1988). Splenocyte natural killer cell activity and metastatic potential are inversely dependent on estrous stage. Surgery, 104, 398-404.
21. HANNA N AND SCHNEIDER M. (1982). Enhancement of tumor metastasis and suppression of natural killer cell activity by β-estradiol treatment. J. Immunol., 130, 974-980.
22. HANNA N. (1985). The role of natural killer cells in the control of tumor growth and metastases. Biochim. Biophys. Acta, 780, 213-226.
23. HERBERMAN RB AND ORTALDO JR. (1981). Natural killer cells: their role in defenses against disease. Science, 214, 24-30.
24. HOU J AND ZHENG WF. (1988). Effect of sex hormones on NK and ADCC activity of mice. Int. J. Immunopharmacol., 10, 15-22.
25. HRUSHESKY WJM, GRUBER SA, SOTHERN RB, HOFFMAN RA, LAKATUA D, CARLSON A, CERRA F AND SIMMONS RL. (1988). Natural killer cell activity: age, estrous- and circadian-stage dependence and inverse correlation with metastatic potential. J. Natl Cancer Inst., 80, 1232-1237.
26. HRUSHESKY WJM, BLUMING AZ, GRUBER SA AND SOTHERN RB. (1989). Menstrual influence on surgical cure of breast cancer. Lancet, 2, 949-952.
27. LAPOLT PS, MATT DW, JUDD HL AND LU JKH. (1986). The relation of ovarian steroid levels in young female rats to subsequent estrous cyclicity and reproductive function during aging. Biol. Reprod., 35, 1131-1139.
28. LEVY S, HERBERMAN RB, LIPPMAN M AND D'ANGELO T. (1987). Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J. Clin. Oncol., 5, 348-353.
29. LYNCH EA, DINARELLO CA AND CANNON JG. (1994). Gender differences in IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion. J. Immunol., 153, 300-306.
30. MATT DW, LAPOLT PS, JUDD HL AND LU JKH. (1986). Estrogen exposure affects the post-ovariectomy increase in both LH and FSH release in female rats. Neuroendocrinology, 42, 21-27.
31. NAPPI RE, GUO AL, PETRAGLIA F, BONATI ME, CRISCUOLO M, FICARRA G, ZARA C AND GENAZZANI AR. (1994). Pituitary and ovarian interleukin-1 alpha content changes according to estrous cycle and acute stress exposure. Gynecol. Endocrinol., 8, 259-264.
32. NEQUIN LG, ALVAREZ J AND SCHWARTZ NB. (1979). Measurement of serum steroid and gonadotropin levels and uterine and ovarian variables throughout 4 day and 5 day estrous cycles in the rat. Biol. Reprod., 20, 659-670.
33. OLDHAM RK. (1990). Natural killer cells: history, relevance, and clinical applications. Nat. Immunol. Cell Growth Regul., 9, 297-312.
34. PAGE GG, BEN-ELIYAHU S, YIRMIYA R AND LIEBESKIND JC. (1993). Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain, 54, 21-28.
35. PAGE GG, BEN-ELIYAHU S AND LIEBESKIND JC. (1994). The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain Behav. Immunol., 8, 241-250.
36. PAGE GG, BEN-ELIYAHU S AND TAYLOR AN. (1995). The development of natural killer cell activity and resistance to tumor metastasis in the Fischer 344 rat. J. Neuroimmunol., 63, 69-77.
37. POLAN ML, DANIELE A AND KUO A. (1988). Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity. Fertil. Steril., 49, 964-968.
38. POLAN ML, LOUKIDES J, NELSON P, CARDING S, DIAMOND M, WALSH A AND BOTTOMLY K. (1989). Progesterone and estradiol modulate interleukin-1 beta messenger ribonucleic acid levels in cultured human peripheral monocytes. J. Clin. Endocrinol. Metab., 69, 1200-1206.
39. POLAN ML, KUO A, LOUKIDES J AND BOTTOMLY K. (1990). Cultured human luteal peripheral monocytes secrete increased levels of interleukin-1. J. Clin. Endocrinol. Metab., 70, 480-484.
40. POLAN ML, LOUKIDES JA AND HONIG J. (1994). Interleukin-1 in human ovarian cells and in peripheral blood monocytes increases during the luteal phase: evidence for a midcycte surge in the human. Am. J. Obstet. Gynecol., 170, 1000-1007.
41. RAPS D, BARTHE PL AND DESAULLES PA. (1971). Plasma and adrenal corticosterone levels during the different phases of the sexual cycle in normal female rats. Experientia, 77, 283-291.
42. RATAJCZAK HV, SOTHERN RB AND HRUSHESKY WJM. (1988). Estrous influence on surgical cure of a mouse breast cancer. J. Exp. Med., 168, 73-82.
43. RAGER DR, COLEMAN KJ AND KLEIN SL. (1994). Cellular and humoral responses to brief acute restraint stress in rats: sex and estrous phase differences. Paper presented at the 27th Annual meeting of the Winter Conference on Brain Research. Workshop organized by BEN-ELIYAHU S. These findings were confirmed by personal communication with Dr Rager. The marker used (5C6) is described in Jaso-Friedmann L, Leary JH, St. John AL, Harris DT, Koren HS and Evans DL. (1992). Cell. Immunol., 141, 131.
44. RAGER DR, COLEMAN KJ AND KLEIN SL. (1994). Cellular and humoral responses to brief acute restraint stress in rats: sex and estrous phase differences. Paper presented at the 27th Annual meeting of the Winter Conference on Brain Research. Workshop organized by BEN-ELIYAHU S. These findings were confirmed by personal communication with Dr Rager. The marker used (5C6) is described in Jaso-Friedmann L, Leary JH, St. John AL, Harris DT, Koren HS and Evans DL. (1992). Cell. Immunol., 141, 131.
45. SAAD Z, BRAMWELL V, DUFF J, GIORTTI M, JORY T, HEATHCOTE G, TURNBULL I, GARCIA I AND STITT L. (1994). Timing of surgery in relation to the menstrual cycle in premenopausal women with operable breast cancer. Br. J. Surg., 81, 217-220.
46. SCHANTZ SP, BROWN BW, LIRA E, TAYLOR DL AND BEDDINGFIELD N. (1987). Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer. Cancer Immunol. Immunother., 25, 141-148.
47. SCREPANTI I, SANTONI A, GULINO A, HERBERMAN RB AND FRATI L. (1987). Estrogen and antiestrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes. Cell Immunol., 106, 191-202.
48. SEAMAN WE AND GINDHARG TD. (1979). Effect of estrogen on natural killer cells. Arthritis Rheumatism, 22, 1234-1240.
49. SENIE RT, ROSEN PP, RHODES P AND LESSER ML. (1991). Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. Ann. Intern. Med., 115, 337-342.
50. SIMON C, PIQUETTE GN, FRANCES A, WESTPHAL LM, HEINRICHS WL AND POLAN ML. (1993). Interleukin-1 type I receptor messenger ribonucleic acid expression in human endomatrium throughout the menstrual cycle. Fertil. Steril., 59, 791-796.
51. SPRATT JS, ZIRNHELD J AND YANCEY JM. (1993). Breast cancer detection demonstration project data can determine whether the prognosis of breast cancer is affected by the time of surgery during the menstrual cycle. J. Surg. Onco., 53, 4-9.
52. SULKE AN, JONES DB AND WOOD PJ. (1985). Variation in natural killer activity in peripheral blood during the menstrual cycle. Br. Med. J., 290, 884-886.
53. VAN DEN BRINK MRM, HUNT LE AND HISERODT JC. (1990). In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats. J. Exp. Med., 171, 197-210.
54. VERONESI U, LUINI A, MARIANI L, DEL VECCHIO M, ALVEZ D, ANDREOLI C, GIACOBONE A, MERSON M, PACETTI G, RASELLI R AND SACCOZZI R. (1994). Effect of menstrual phase on surgical treatment of breast cancer. Lancet, 343, 1545-1547.
55. VIAU V AND MEANEY MJ. (1991). Variations in the hypothalamic-pituitary-adrenal response to stress during the estrous cycle in the rat. Endocrinology, 129, 2503-2511.
56. VIDALLER A, GUADARRAMA F, LLORENTE L, MENDEZ JP, LARREA F, VILLA AR AND ALARCON-SEGOVIA D. (1992). Hyperprolactinemia inhibits natural killer (NK) cell function in vivo and its bromocriptine treatment not only corrects it but makes it more efficient. J. Clin. Immunol., 12, 210-215.
57. WHITE D, JONES DB, COOKE T AND KIRKHAM N. (1982). Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast cancer disease. Br. J. Cancer, 46, 611-616.
58. WILTROUT RH, HERBERMAN RB, ZHANG S, CHIRIGOS MA, ORTALDO JR, GREEN KM AND TALMADGE JE. (1985). Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J. Immunol., 134, 4267-4274.
59. YIRMIYA R, SHAVIT Y, BEN-ELIYAHU S, GALE RP, LEIBESKIND JC, TAYLOR AN AND WEINER H. (1991). Modulation of immunity and neoplasia by neuropeptides released by stressors. In Neuropeptides and Systemic Diseases. McCubbin JA, Kaufmann PG and Nemeroff CB, (eds). pp. 261-286. Academic Press: San Diego.
60. YIRMIYA R, BEN-ELIYAHU S, GALE RP, SHAVIT Y, LIEBISKIND JC AND TAYLOR AN. (1992). Ethanol increases tumor progression in rats: possible involvement of natural killer cells. Brain Behav. Immunol., 6, 74-86.